sodium(2R,3R,4S)-4-hydroxy-2-(((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-((sulfonatooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-(sulfonatooxy)-3,4-dihydro-2H-pyran-6-carboxylate; Methyl 2-Deoxy-4-O-(4-deoxy-2-O-sulfo-?-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-?-D-glucopyranoside 6-(Hydrogen Sulfate) Sodium Salt (1:4)
Fondaparinux sodium impurity 1 is a fully characterized chemical compound used as a reference standard of API Fondaparinux. The standard offered is compliant with regulatory guidelines. Fondaparinux sodium impurity 1 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 348625-84-3
